In 2023, the FDA approved Zepbound for long-term weight management in adults living with obesity or excess weight accompanied by a related health issue
GLP-1 friendly lunch meals Lunch sits at the midpoint of your day, and for most GLP-1 users, it falls in the sweet spot where appetite has returned slightly from the morning suppression but has not yet hit the afternoon wall
Semaglutide pulls one lever
Another scenario is a patient who has been using a GLP-1 therapy for a few years, has reached a weight-loss plateau, and is now in the maintenance phase of treatment
[4]El-Shehawi AM, Rahman MA, et al
K stands as the guiding force behind our team of thyroid specialists, endocrinologists, and regenerative medicine experts, championing a vision that extends beyond conventional treatment paradigms